Search
Search Constraints
You searched for: Author/Creator Torregrosa, RobertLimit your search
- Torregrosa, Robert [remove] 1
- 615.19 1
- AAA α-aminoamide -- ASD antiseizure drug -- ASP Anticonvulsant Screening Program -- CAD catecholamine A-differentiated -- CNS central nervous system -- ED50 effective dose (50%) -- FAA functionalized amino acid -- IBCF isobutyl chloroformate -- IC50 concentration at which half of the channels have transitioned to a slow-inactivated state -- ip intraperitoneally -- MAC mixed anhydride coupling -- MES maximal electroshock seizure -- NINDS National Institutes of Neurological Disorders and Stroke -- NMM N-methylmorpholine -- NOAEL no observed adverse effect level -- OCF3 trifluoromethoxy -- PI protective index -- po orally -- RMP resting membrane potential -- SAR structure activity relationship -- scMet scMetrazol -- TD50 neurological impairment (toxicity, 50%) -- TEA-Cl tetraethylammonium chloride -- V1/2 voltage of half-maximal (in)activation -- VGSC voltage-gated sodium channel 1
- Biochemistry -- Periodicals 1
- Bioorganic chemistry -- Periodicals 1
- Chemistry, Clinical -- Periodicals 1
- Chemistry, Organic -- Periodicals 1
- Chimeric agents -- Functionalized amino acids -- α-Aminoamides -- Antiseizure agents -- Na+ current inhibition 1
- Chimie bio-organique -- Périodiques 1
- Chimie pharmaceutique -- Périodiques 1
- Pharmaceutical chemistry -- Periodicals 1